However, when adding dopamine transporter (DAT) single-photon emission computed tomography (SPECT) as an enrichment screen, 14 of 21 with a DAT-SPECT deficit (and hyposmia) developed PD, resulting in a PPV of 67%. This evidence concerns the gene SLC6A3 and Parkinson disease.